Antithymocyte-globulin/ciclosporinNo response: 7 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1888卷 / 1期

关键词：

D O I：

10.1007/s40278-022-08413-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：71 / 71

相关论文

共 50 条

[41] Antithymocyte-globulin/ciclosporinLack of efficacy
Reactions Weekly, 2024, 2002 (1) : 70 - 70
[42] Antithymocyte-globulin/eculizumab/rituximabLack of efficacy: case report
Reactions Weekly, 2025, 2059 (1) : 49 - 49
[43] Antithymocyte-globulin/eculizumabLack of efficacy
Reactions Weekly, 2024, 2012 (1) : 50 - 50
[44] Antithymocyte-globulin/cyclophosphamide/fludarabineLack of efficacy: case report
Reactions Weekly, 2024, 2030 (1) : 60 - 60
[45] Antithymocyte-globulin/Busulfan/FludarabineLack of efficacy: case report
Reactions Weekly, 2024, 2039 (1) : 71 - 71
[46] Antithymocyte-globulin/cyclophosphamide/fludarabineLack of efficacy: case report
Reactions Weekly, 2023, 1967 (1) : 62 - 62
[47] Antithymocyte-globulin/steroids/tacrolimusEpisode of convulsion: case report
Reactions Weekly, 2019, 1756 (1) : 50 - 50
[48] Antithymocyte-globulin/busulfan/cyclophosphamideLack of efficacy: case report
Reactions Weekly, 2022, 1914 (1) : 84 - 84
[49] Antithymocyte-globulin/penicillamineArthus reaction and antineutrophilic cytoplasmic antibody‑positive vasculitis: 2 case reports
Reactions Weekly, 2022, 1897 (1) : 65 - 65
[50] Antithymocyte-globulin/Methotrexate/TacrolimusLack of efficacy: case report
Reactions Weekly, 2024, 2033 (1) : 43 - 43

← 1 2 3 4 5 →